Thyroid C-cell Tumors: In rodent experiments, semaglutide continues to be revealed to lead to thyroid C-cell tumors. It is unknown no matter if this risk applies to humans, but semaglutide is contraindicated in patients with a personal or family background of medullary thyroid carcinoma (MTC) or sufferers with Several Endocrine Neoplasia syndrome s